In late trade S&P/ASX 200 index is having a subdued end to the day ahead of the Christmas break. At the time of writing the benchmark index is flat at 6,786.7 points.
Four shares that are out of form on Tuesday are listed below. Here’s why these ASX shares are dropping lower:
The Challenger Ltd (ASX: CGF) share price is down 2% to $8.27 on the back of no news. However, earlier this week Vicinity Centres (ASX: VCX) announced the divestment of its 50% interest in Lennox Village in New South Wales for $31.5 million to joint-owner Challenger in a simultaneous exchange and settlement on December 11 2019. Some investors may not be keen on the transaction.
The Novita Healthcare Ltd (ASX: NHL) share price has crashed 16.5% lower to 4.5 cents. Investors have been selling Novita Healthcare’s shares amid unsubstantiated claims that its Tali Detect product performed poorly in a test by Monash University. TALi Detect is a 20-min digital game-based screening tool available to all children to assess potential attention deficits. It recently received a determination that it can be delivered via the U.S. Reimbursement Code system.
The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price is down 2% to $2.82. Investors have been selling the biopharmaceutical company’s shares despite there being no news out of it. However, with its shares up materially this year, I suspect this could be down to profit taking from some investors.
The Xero Limited (ASX: XRO) share price has fallen 3% to $80.90. This also appears to be a case of profit taking after a strong gains were made on Monday. Yesterday’s gain sent Xero’s shares to an all-time high of $84.45. When the business and accounting software company’s shares hit that level, it meant they had gained a whopping 101% since the start of the year.
The post Why Challenger, Novita, Paradigm, and Xero are dropping lower appeared first on Motley Fool Australia.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool Australia owns shares of Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019